DLA PIPER LLP (US)

Lobbying for INTRA-CELLULAR THERAPIES, INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

New York

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.